Selected research
Industry Growth & Trends
Global Pharmaceutical Safety Assessment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pharmaceutical Safety Assessment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Safety Assessment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pharmaceutical Safety Assessment market include Eurofins, LabCorp, Fujifilm Wako, Charles River, SGS, Intertek Group, CTI, Frontage and Medicilon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharmaceutical Safety Assessment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmaceutical Safety Assessment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Safety Assessment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Safety Assessment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Safety Assessment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmaceutical Safety Assessment Market by Company
Eurofins
LabCorp
Fujifilm Wako
Charles River
SGS
Intertek Group
CTI
Frontage
Medicilon
Wuxi Biologics
Pharmaron
Pharmaceutical Safety Assessment Segment by Type
Biological Drugs
Chemical Drugs
Pharmaceutical Safety Assessment Segment by Application
Clinical
Non-clinical
Pharmaceutical Safety Assessment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Safety Assessment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Safety Assessment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Safety Assessment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharmaceutical Safety Assessment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Drugs
- Chemical Drugs
Applications
- Clinical
- Non-clinical
Companies covered
- Eurofins
- LabCorp
- Fujifilm Wako
- Charles River
- SGS
- Intertek Group
- CTI
- Frontage
- Medicilon
- Wuxi Biologics
- Pharmaron
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharmaceutical Safety Assessment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharmaceutical Safety Assessment Market Size by Region (2021-2032)
- 1.4.1 Global Pharmaceutical Safety Assessment Market Size by Region (2021-2026)
- 1.4.2 Global Pharmaceutical Safety Assessment Market Size by Region (2027-2032)
- 1.5 Key Regions Pharmaceutical Safety Assessment Market Size (2021-2032)
- 1.5.1 North America Pharmaceutical Safety Assessment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharmaceutical Safety Assessment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharmaceutical Safety Assessment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharmaceutical Safety Assessment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharmaceutical Safety Assessment Market Size Growth Rate (2021-2032)
2 Pharmaceutical Safety Assessment Market by Type
- 2.1 Type Introduction
- 2.1.1 Biological Drugs
- 2.1.2 Chemical Drugs
- 2.2 Global Pharmaceutical Safety Assessment Market Size by Type
- 2.2.1 Global Pharmaceutical Safety Assessment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharmaceutical Safety Assessment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharmaceutical Safety Assessment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharmaceutical Safety Assessment Market Size by Regions
- 2.3.1 North America Pharmaceutical Safety Assessment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharmaceutical Safety Assessment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharmaceutical Safety Assessment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharmaceutical Safety Assessment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharmaceutical Safety Assessment Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Safety Assessment Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical
- 3.1.2 Non-clinical
- 3.2 Global Pharmaceutical Safety Assessment Market Size by Application
- 3.2.1 Global Pharmaceutical Safety Assessment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharmaceutical Safety Assessment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharmaceutical Safety Assessment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharmaceutical Safety Assessment Market Size by Regions
- 3.3.1 North America Pharmaceutical Safety Assessment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharmaceutical Safety Assessment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharmaceutical Safety Assessment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharmaceutical Safety Assessment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharmaceutical Safety Assessment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharmaceutical Safety Assessment Industry Trends
- 4.2 Pharmaceutical Safety Assessment Industry Drivers
- 4.3 Pharmaceutical Safety Assessment Industry Opportunities and Challenges
- 4.4 Pharmaceutical Safety Assessment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharmaceutical Safety Assessment Revenue (2021-2026)
- 5.2 Global Pharmaceutical Safety Assessment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharmaceutical Safety Assessment Key Company Headquarters & Area Served
- 5.4 Global Pharmaceutical Safety Assessment Company, Product Type & Application
- 5.5 Global Pharmaceutical Safety Assessment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharmaceutical Safety Assessment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharmaceutical Safety Assessment Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharmaceutical Safety Assessment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eurofins
- 6.1.1 Eurofins Company Information
- 6.1.2 Eurofins Business Overview
- 6.1.3 Eurofins Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eurofins Pharmaceutical Safety Assessment Product Portfolio
- 6.1.5 Eurofins Recent Developments
- 6.2 LabCorp
- 6.2.1 LabCorp Company Information
- 6.2.2 LabCorp Business Overview
- 6.2.3 LabCorp Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 LabCorp Pharmaceutical Safety Assessment Product Portfolio
- 6.2.5 LabCorp Recent Developments
- 6.3 Fujifilm Wako
- 6.3.1 Fujifilm Wako Company Information
- 6.3.2 Fujifilm Wako Business Overview
- 6.3.3 Fujifilm Wako Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fujifilm Wako Pharmaceutical Safety Assessment Product Portfolio
- 6.3.5 Fujifilm Wako Recent Developments
- 6.4 Charles River
- 6.4.1 Charles River Company Information
- 6.4.2 Charles River Business Overview
- 6.4.3 Charles River Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Charles River Pharmaceutical Safety Assessment Product Portfolio
- 6.4.5 Charles River Recent Developments
- 6.5 SGS
- 6.5.1 SGS Company Information
- 6.5.2 SGS Business Overview
- 6.5.3 SGS Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 SGS Pharmaceutical Safety Assessment Product Portfolio
- 6.5.5 SGS Recent Developments
- 6.6 Intertek Group
- 6.6.1 Intertek Group Company Information
- 6.6.2 Intertek Group Business Overview
- 6.6.3 Intertek Group Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Intertek Group Pharmaceutical Safety Assessment Product Portfolio
- 6.6.5 Intertek Group Recent Developments
- 6.7 CTI
- 6.7.1 CTI Company Information
- 6.7.2 CTI Business Overview
- 6.7.3 CTI Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 CTI Pharmaceutical Safety Assessment Product Portfolio
- 6.7.5 CTI Recent Developments
- 6.8 Frontage
- 6.8.1 Frontage Company Information
- 6.8.2 Frontage Business Overview
- 6.8.3 Frontage Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Frontage Pharmaceutical Safety Assessment Product Portfolio
- 6.8.5 Frontage Recent Developments
- 6.9 Medicilon
- 6.9.1 Medicilon Company Information
- 6.9.2 Medicilon Business Overview
- 6.9.3 Medicilon Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Medicilon Pharmaceutical Safety Assessment Product Portfolio
- 6.9.5 Medicilon Recent Developments
- 6.10 Wuxi Biologics
- 6.10.1 Wuxi Biologics Company Information
- 6.10.2 Wuxi Biologics Business Overview
- 6.10.3 Wuxi Biologics Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Wuxi Biologics Pharmaceutical Safety Assessment Product Portfolio
- 6.10.5 Wuxi Biologics Recent Developments
- 6.11 Pharmaron
- 6.11.1 Pharmaron Company Information
- 6.11.2 Pharmaron Business Overview
- 6.11.3 Pharmaron Pharmaceutical Safety Assessment Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Pharmaron Pharmaceutical Safety Assessment Product Portfolio
- 6.11.5 Pharmaron Recent Developments
7 North America
- 7.1 North America Pharmaceutical Safety Assessment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 7.3 North America Pharmaceutical Safety Assessment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharmaceutical Safety Assessment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 8.3 Europe Pharmaceutical Safety Assessment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Safety Assessment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharmaceutical Safety Assessment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharmaceutical Safety Assessment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 10.3 South America Pharmaceutical Safety Assessment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Safety Assessment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharmaceutical Safety Assessment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharmaceutical Safety Assessment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst